ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Aro Biotherapeutics signs licensing agreement worth up to $1.4bn pharmaceutical-technology
January 13, 2020Aro Biotherapeutics, a biotech firm engaged in the development of protein biologics called Centyrins, has signed a licencing deal that can potentially generate up to $1.4bn for the company. -
Janssen alums' Aro Biotherapeutics takes aim at centyrins with $13M round
fiercebiotech
December 27, 2018A pair of former Janssen R&D leaders founded Aro Biotherapeutics early this year to develop centyrins—small proteins that could potentially work like antibodies without the accompanying challenges..... -
Isogenica inks licensing deal with Aro Biotherapeutics for development of scaffold molecules
fiercebiotech
July 31, 2018Isogenica has inked a?licensing deal?with Aro Biotherapeutics to use its in vitro polypeptide display systems for the development of Aro’s scaffold molecule technology.
Pharma Sources Insight January 2025
